Key points are not available for this paper at this time.
These data suggest that dapagliflozin has the potential to be an efficacious treatment for type 2 diabetes.
Building similarity graph...
Analyzing shared references across papers
Loading...
Song‐Ping Han
Peking University
Deborah Hagan
Janssen (United States)
Joseph R. Taylor
Bristol-Myers Squibb (Germany)
Diabetes
Bristol-Myers Squibb (United States)
Novartis (United States)
Boston Biomedical Research Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Han et al. (Fri,) studied this question.
synapsesocial.com/papers/69d862c205ee2ba81dbefa42 — DOI: https://doi.org/10.2337/db07-1472